← Back to headlines
Definium Therapeutics Targets Three Phase III Readouts in 2026
Definium Therapeutics plans for three pivotal Phase III readouts in 2026, with enrollment progressing and its cash runway extended into 2028.
27 Feb, 02:58 — 27 Feb, 02:58
ℹOnly 1 source covers this story
